Pancreatic Cancer Research

ResearcherPlymouth HospitalActive in the last 2 years

Somaiah Aroori

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5613-6463; OpenAlex author ID A5029305528. Sources: ClinicalTrials.gov.

Their work

Papers
11 (first author 2, last author 1)
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
49
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: 1 trial · 2021: 1 paper · 2022: none · 2023: 4 papers · 2024: 1 paper · 2025: 3 papers

Papers 11

  1. Patterns, timing and predictors of recurrence following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: an international multicentre retrospectiv… Co-author DOI 10.1016/j.hpb.2024.11.015↗
  2. Long-term Outcomes Following Resection of Adenocarcinoma Arising from Intraductal Papillary Mucinous Neoplasm (A-IPMN) Versus Pancreatic Ductal Adenocarcinoma … Co-author DOI 10.1097/sla.0000000000006272↗
  3. Venous Resection During Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma-A Multicentre Propensity Score Matching Analysis of the Recurrence After Whi… First author DOI 10.3390/cancers17071223↗
  4. Five-year recurrence/survival after pancreatoduodenectomy for pancreatic adenocarcinoma: does pre-existing diabetes matter? Results from the Recurrence After W… First author DOI 10.1016/j.hpb.2024.04.010↗
  5. Determination of "borderline resectable" pancreatic cancer - A global assessment of 30 shades of grey. Co-author DOI 10.1016/j.hpb.2023.07.883↗
  6. The impact of the COVID-19 pandemic upon pancreatic cancer treatment (CONTACT Study): a UK national observational cohort study. Co-author DOI 10.1038/s41416-023-02220-2↗
  7. Does an extensive diagnostic workup for upfront resectable pancreatic cancer result in a delay which affects survival? Results from an international multicentr… Last author DOI 10.14701/ahbps.23-042↗
  8. Preoperative C-Reactive Protein-to-Albumin Ratio and Its Ability to Predict Outcomes of Pancreatic Cancer Resection: A Systematic Review. Co-author DOI 10.3390/biomedicines11071983↗
  9. Impact of SARS-CoV-2 pandemic on pancreatic cancer services and treatment pathways: United Kingdom experience. Co-author DOI 10.1016/j.hpb.2021.03.003↗
  10. Impact of portal vein infiltration and type of venous reconstruction in surgery for borderline resectable pancreatic cancer. Co-author DOI 10.1002/bjs.10580↗
  11. Outcome after pancreaticoduodenectomy for T3 adenocarcinoma: A multivariable analysis from the UK Vascular Resection for Pancreatic Cancer Study Group. Co-author DOI 10.1016/j.ejso.2015.08.158↗

Trials 1

  1. Recurrence After Whipple's (RAW) Study Principal investigator NCT04596865↗

Closest collaborators

The 25 strongest of 49 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Keith John Roberts · 4 shared papers, 2021–2025 · strength 0.53
  2. Duncan R.C. Spalding · 3 shared papers, 2021–2025 · strength 0.36
  3. Ricky Harminder Bhogal · 3 shared papers, 2021–2025 · strength 0.36
  4. Adam Enver Frampton · 3 shared papers, 2021–2025 · strength 0.36
  5. Alberto Porcu · 2 shared papers, 2023–2025 · strength 0.28
  6. Thomas Brendon Russell · 2 shared papers, 2023–2025 · strength 0.28
  7. Fabio Ausania · 2 shared papers, 2023–2025 · strength 0.28
  8. Ismael Domínguez-Rosado · 2 shared papers, 2023–2025 · strength 0.28
  9. Dhanny Gomez · 2 shared papers, 2023–2025 · strength 0.28
  10. Brian Ritchie Davidson · 2 shared papers, 2023–2025 · strength 0.28
  11. Manuel Maglione · 2 shared papers, 2023–2025 · strength 0.28
  12. Peter Lawrence Zaki Labib · 2 shared papers, 2023–2025 · strength 0.28
  13. Andrew Malvern Smith · 2 shared papers, 2023–2025 · strength 0.28
  14. Zaed Z. R. Hamady · 2 shared papers, 2023–2025 · strength 0.28
  15. Daniel Gerald Croagh · 2 shared papers, 2023–2025 · strength 0.28
  16. Elizabeth Pando Rau · 2 shared papers, 2023–2025 · strength 0.28
  17. Bilal A. Al-Sarireh · 2 shared papers, 2021–2025 · strength 0.24
  18. Stephen J. Wigmore · 3 shared papers, 2015–2021 · strength 0.17
  19. David A. Stell · 3 shared papers, 2015–2021 · strength 0.17
  20. Shahin Hajibandeh · 1 shared paper, 2023 · strength 0.17
  21. Thomas Satyadas · 1 shared paper, 2023 · strength 0.17
  22. Shahab Hajibandeh · 1 shared paper, 2023 · strength 0.17
  23. Tejinderjit Athwal · 1 shared paper, 2023 · strength 0.17
  24. Daren A. Subar · 1 shared paper, 2023 · strength 0.17
  25. Ruben Bellotti · 1 shared paper, 2025 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.